Omeros Corporation
OMER
£2.97
Share price
-4.34%
Change (1 day)
-29.07%
Change (1 year)
Categories
Revenue for Omeros Corporation (OMER)
Revenue in 2025 (TTM): N/A
In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Omeros Corporation from 2009 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2025 (TTM)  | N/A | |
| 2024 | N/A | |
| 2023 | N/A | |
| 2022 | N/A | -100% |
| 2021 | -£59.19 Million | -209.29% |
| 2020 | £54.15 M | -36.49% |
| 2019 | £85.26 M | 262.37% |
| 2018 | £23.52 M | -50.95% |
| 2017 | £47.96 M | 42.21% |
| 2016 | £33.72 M | 269.99% |
| 2015 | £9.11 M | 2533.13% |
| 2014 | £0.34 M | -64.31% |
| 2013 | £0.96 M | -73.97% |
| 2012 | £3.72 M | 28.01% |
| 2011 | £2.91 M | 113.45% |
| 2010 | £1.36 M | 52.81% |
| 2009 | £0.89 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Eterna Therapeutics ERNA | £0.4 M | N/A | 🇺🇸 USA |
 Genetic Technologies GENE | £12.8 M | N/A | 🇦🇺 Australia |
 Pfizer PFE | £46.77 B | N/A | 🇺🇸 USA |
 Johnson & Johnson JNJ | £66.89 B | N/A | 🇺🇸 USA |